Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05413> ?p ?o ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05413 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05413 label "T-1249 [drugbank:DB05413]" assertion.
- drugbank:DB05413 seeAlso DB05413 assertion.
- drugbank:DB05413 description "T-1249 is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast track designation from the FDA and is in Phase I/II clinical testing." assertion.
- drugbank:DB05413 identifier "drugbank:DB05413" assertion.
- drugbank:DB05413 title "T-1249" assertion.
- drugbank:DB05413 drugbank_vocabulary:x-pubchemcompound pubchem.compound:16130644 assertion.
- drugbank:DB05413 drugbank_vocabulary:x-chemspider chemspider:17287364 assertion.
- drugbank:DB05413 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05413 drugbank_vocabulary:drugbank-id "DB05413" assertion.
- drugbank:DB05413 bio2rdf_vocabulary:x-identifiers.org DB05413 assertion.
- drugbank:DB05413 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05413" assertion.
- drugbank:DB05413 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05413 bio2rdf_vocabulary:identifier "DB05413" assertion.